Increasing Prevalence of Infectious Diseases and Emergence of Covid-19 to Augment Growth of Vaccine Adjuvant Market
In immunology, an adjuvant is any material that enhances and/or decreases the immune response to a vaccine or other agent. The word "adjuvant" derives from the Latin phrase adiuvare, which means to assist or help. The usual definition of an adjuvant in this context is a substance added to enhance the effectiveness of a biological agent or product in the process of eliciting an immune response. Market Dynamics Increasing prevalence of infectious diseases is expected to propel growth of the global vaccine adjuvant market. For instance, in May 2019, according to the study, ‘Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda’, published in May 2019, in BMC Infectious Diseases, the prevalence of hepatitis B surface antigen was 3.9% in the study population. Moreover, increasing adoption of adjuvant technologies is also expected to aid in growth of the market. For instance, in January 2021, Oragenics, a developer of antibiotics...